Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 8701 - 8725 of 10977 in total
Ethylene oxide/propylene oxide copolymer is used as a food additive. It belongs to the family of Epoxides. These are compounds containing a cyclic ether with three ring atoms (one oxygen and two carbon atoms).
Investigational
Vet approved
Adherex's biotechnology compound, ADH-1, targets N-cadherin, a protein present on certain tumor cells and established tumor blood vessels. ADH-1 is currently in clinical development in a combination program with a range of chemotherapeutic agents to investigate the synergistic effects noted in our preclinical models. At the end of 2006, the...
Investigational
Matched Synonyms: … l-cysteinamide, n-acetyl-l-cysteinyl-l-histidyl-l-alanyl-l-valyl-, cyclic (1-5)-disulfide …
Pazufloxacin is under investigation in clinical trial NCT02592096 (Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol).
Investigational
Matched Iupac: … (2S)-6-(1-aminocyclopropyl)-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.0⁵,¹³]trideca-5(13),6,8,11 …
HMI-102 is an investigational gene therapy designed to encode the phenylalanine-4-hydroxylase (PAH) gene, mutated in people with phenylketonuria.
Investigational
Experimental
Matched Name: … 5-Phenylsulfanyl-2,4-Quinazolinediamine …
Matched Iupac: … 5-(phenylsulfanyl)quinazoline-2,4-diamine …
Experimental
Matched Name: … 5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID …
Matched Iupac: … 5-[2-(trifluoromethoxy)phenyl]furan-2-carboxylic acid …
Experimental
Matched Name: … 5-methyl-6-phenylquinazoline-2,4-diamine …
Matched Iupac: … 5-methyl-6-phenylquinazoline-2,4-diamine …
C-CAR039 is an autologous Chimeric Antigen Receptors (CAR) T-cell therapy expressing CD19/CD20 bi-specific CAR.
Investigational
INO-4800 is a DNA vaccine containing the full sequence for the SARS-CoV-2 Spike (S) protein in development for immunization against COVID-19. Early in vitro studies using HEK-293T cells demonstrated that the transfection of INO-4800 results in the expression of S protein by human cells.[A214475, A214478] Follow up studies in both...
Investigational
Matched Description: … (NCT04336410) was started on April 3, 2020, with an expected completion date of July 2021. …
Experimental
Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.
Withdrawn
Experimental
Matched Iupac: … (1R,2R,5R,8R,9S,10R,11S,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1^{5,8} …
Nalorphine is a mixed opioid agonist–antagonist. It acts at two opioid receptors—at the mu receptor it has antagonistic effects, and at the kappa receptors it exerts high-efficacy agonistic characteristics. It is used to reverse opioid overdose and (starting in the 1950s) in a challenge test to determine opioid dependence.
Experimental
Vet approved
Matched Iupac: … (1S,5R,13R,14S,17R)-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca …
The use of the plant species Cannabis sativa and Cannabis indica, popularly known as marijuana, has gained popularity in recent years for the management of a wide variety of medical conditions as a wave of legalization in North America has changed public and medical opinion on its use. Consequently, an...
Experimental
Investigational
Matched Description: … There is further evidence that CBD also activates 5-HT1A serotonergic and TRPV1–2 vanilloid receptors …
Experimental
Matched Name: … 5-(2-Chlorophenyl)Furan-2-Carboxylic Acid …
Matched Iupac: … 5-(2-chlorophenyl)furan-2-carboxylic acid …
Experimental
Matched Name: … 5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID …
Matched Iupac: … 5-[2-(trifluoromethyl)phenyl]furan-2-carboxylic acid …
Experimental
Matched Name: … 5-(2-chlorophenyl)furan-2-carbohydrazide …
Matched Iupac: … 5-(2-chlorophenyl)furan-2-carbohydrazide …
Displaying drugs 8701 - 8725 of 10977 in total